Walid S H Elsayed
Overview
Explore the profile of Walid S H Elsayed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elsayed W, Harb O, Alabiad M, Faraj Saad R, Anbaig A, Alorini M, et al.
Iran J Pathol
. 2023 Aug;
18(2):180-192.
PMID: 37600577
Background & Objective: Cells of renal cell carcinoma (RCC) are resistant to the most currently used chemotherapeutic agents and targeted therapies; hence, we evaluated the expression of NEK2, JMJD4, and...
2.
Abdul-Maksoud R, Elsayed W, Rashad N, Elsayed R, Elshorbagy S, Hamed M
Gene
. 2022 May;
834:146597.
PMID: 35598685
Background: Glucagon like peptide-1 receptor (GLP-1R) agonist usage has previously been linked to an elevated incidence of thyroid cell adenomas and carcinomas in animals. Aim: The goal of this study...
3.
Hafez A, Seleem M, Alattar A, Elshorbagy S, Elsayed W
Contemp Oncol (Pozn)
. 2022 Jan;
25(4):279-290.
PMID: 35079236
Aim Of The Study: The clinical significance and predictive and prognostic value of HuR, RBM3, and PODXL expression in patients with urothelial bladder cancer (UBC) are not clear yet. The...
4.
Abdul-Maksoud R, Rashad N, Elsayed W, Elsayed R, Sherif M, Abbas A, et al.
J Gene Med
. 2021 Jul;
23(12):e3381.
PMID: 34312940
Background: Long non-coding RNA ADAM metallopeptidase with thrombospondin type 1 motif, 9 antisense RNA 2 (ADAMTS9-AS2) was recognized as a novel tumor suppressor and plays an important role in the...
5.
Obaya A, Mohammed A, Rashied H, Morsy A, Osman G, Allam A, et al.
Asian Pac J Cancer Prev
. 2021 Apr;
22(4):1025-1034.
PMID: 33906293
Background: Despite the significant progress in target therapy for the treatment of metastatic colorectal carcinoma (mCRC), the overall survival isn't satisfactory. Methods: We assessed the expression of Amphiregulin, PTEN, and...
6.
Abdul-Maksoud R, Rashad N, Elsayed W, Ali M, Kamal N, Zidan H
J Gene Med
. 2021 Feb;
23(5):e3326.
PMID: 33617143
Background: MicroRNAs (miRNAs) contribute to the development and progression of systemic lupus erythematosus (SLE) by affecting a wide range of targeted genes and facilitating the development of lupus nephritis (LN)....
7.
Abdul-Maksoud R, Elsayed R, Elsayed W, Sediq A, Rashad N, Shaker S, et al.
Biotechnol Appl Biochem
. 2020 Jul;
68(4):732-743.
PMID: 32678466
Circulating miRNAs gathered much interest in cancer research as noninvasive biomarkers. The aim of this study was to analyze the expression of miR-29c and miR-149 among colorectal cancer (CRC) patients...
8.
Zidan H, Abdul-Maksoud R, Mowafy H, Elsayed W
Cytokine
. 2018 Mar;
108:115-119.
PMID: 29602154
Deregulated immunity is one of the most important factors implicated in recurrent pregnancy loss (RPL). The possible role of interleukin-33 (IL-33) and forkhead/winged helix transcription factor (Foxp3) in RPL have...
9.
Zidan H, Abdul-Maksoud R, Elsayed W, Desoky E
IUBMB Life
. 2018 Mar;
70(5):437-444.
PMID: 29522280
Prostate cancer (PCa) is considered the most common malignancy in men. The aim of this study is to assess the role of serum miR-15a and miR-16-1 expression in PCa development,...
10.
Abdul-Maksoud R, Shalaby S, Elsayed W, Elkady S
Gene
. 2016 Jun;
591(2):320-6.
PMID: 27259667
Background: Tumor grade and stage are currently the most important prognostic variables in bladder cancer but establishing additional criteria is still needed for effective treatment. Objectives: The aim of the...